Surgical Simulation Market

The report "Surgical Simulation Market by Offering (General [Laparoscopic], Robotic, Cardio [Interventional], Neuro [Cranial, Spine], Software), Type (High fidelity), Technology (AR/VR), Use Case (Training, R&D), End User (Hospitals) - Global Forecast by 2030",  is projected to grow from USD 176.0 million in 2025 and to reach USD 349.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.7% during the forecast period.

Browse 300 market data Tables and 50 Figures spread through 350 Pages and in-depth TOC on "Surgical Simulation Market by Offering (General [Laparoscopic], Robotic, Cardio [Interventional], Neuro [Cranial, Spine], Software), Type (High fidelity), Technology (AR/VR), Use Case (Training, R&D), End User (Hospitals) - Global Forecast by 2030"
View detailed Table of Content here -  https://www.marketsandmarkets.com/Market-Reports/surgical-simulation-market-118859434.html

The global surgical simulation market is experiencing a high momentum, precipitated by the growth of value-based care models, increased patient safety needs, and structural changes in surgical training trajectory across the entire globe. With the growing integration of reimbursement and institutional performance with surgeon efficiency, outcome accuracy, and reduction in complications, simulation has become an essential instrument in enhancing procedural stability and reducing unnecessary harm. Surgical morbidity has high economic costs. Cost accounting research among US hospitals indicates that 30-day post-operative outcomes like prolonged ventilation, unplanned intubation, and renal failure incur huge direct costs, which supports the research goals of global interest in simulation-based skill validation and outcome enhancement. These are heightened by the magnitude of surgical risk in the global scene: the number of major surgeries carried out annually is about 312.9 million, with an approximate 7%-15% of patients developing complications after surgery. According to the World Health Organization, 1 out of 10 patients worldwide incur harm during any healthcare delivery, and 134 million adverse events every year are recorded in the hospitals of low- and middle-income countries, which supports the necessity of standardized and simulation-based safety systems. Market innovation is also moving faster to procedure-specific and variable anatomy simulators, which allow more realistic and patient-representative training in a wide range of surgical scenarios and healthcare environments around the world. For example, in January 2025, InSimo and VirtaMed strengthened their partnership to launch a high-fidelity suturing simulation module as part of the new RoboS robotic surgery simulator, designed to enhance realistic robotic procedural training, especially for suturing skills that vary by anatomy and task complexity.

The training segment held the largest market share in the use case segment of the surgical simulation market in 2024.

The surgical simulation market is divided into training, surgical procedure rehearsal & planning, competency assessment & validation, device & product training, research & development, and other applications based on use case. The training segment is the largest use case as it is a core component of surgical education and workforce development. The training hegemony is closely associated with the consistent holes in physical training faculties and the high unmet demand for scalable learning based on simulation. In a significant survey of European urology training, it was found that of the 183 centers surveyed, only 50.3% were equipped with a dry-lab facility, 31.5% with a virtual reality training center, and just 16.2% with a wet-lab center, and so a need to fill these gaps by utilizing surgical simulation platforms. Parallel to this, the demand side pressure is also very high, with a 2024 simulation study involving arthroscopy in surgical residents indicating that 89.5% of surgical residents desire more simulation in their training, even in well-equipped programs. Moreover, the efficiency of simulation-based training is still clinically proven: in a 2025 study of robotic simulation training of future residents, statistical significance was proven in confidence improvement (p < 0.0001) after a 4-hour session, and knowledge scores rose to 42 and 100, respectively, in the post-training period. The combination of these infrastructure limitations, high demand for trainees, and the established training results, in turn, directly supports the fact that training is the largest use case segment of the surgical simulation market.

The high-fidelity surgical simulators segment held the largest market share by Type segment of the surgical simulation market in 2024.

Based on type, the market is segmented into high-fidelity, medium-fidelity, low-fidelity, and hybrid surgical simulators. The high-fidelity systems segment dominated in 2024 because they are able to recreate real-world surgical conditions with a high level of anatomical, visual, and tactile realism. These simulators combine new technologies (AR/VR, haptics, real-time physiological feedback, and AI-driven performance analytics) and are vital for teaching complex, minimally invasive, and robotic operations, where precision and skill transfer are crucial. Their superiority is also enhanced by the increased focus on patient safety, minimization of intraoperative errors, and competency-based surgical education in teaching hospitals and advanced training facilities. Innovation in the industry only enhances this leadership, such as in October 2025, Surgical Science introduced RobotiX Express, a portable, high-fidelity robotic surgery simulator providing high-fidelity immersive training in a small, suitcase-sized package. Such advancements, by removing the need to be in the operating room to train a complex robotic skill and allowing practice of that skill anywhere and at any time, increase access without compromising high-fidelity realism, which directly explains why high-fidelity surgical simulators still control the market.

The hospitals segment was the largest end user of surgical simulation in 2024.

Based on end user, the market is segmented into hospitals, academic medical centers, military organizations, and other end users. The leading market share of the hospitals segment is largely attributed to the high volume of surgical procedures, the wide variety of procedures, and the growing complexity of cases in hospitals, which create a long-standing need for high-level training that is simulation based to create better surgeon preparedness and patient safety. Hospitals are also the main residency training centers, credentialing, and lifelong learning centers, which promotes the adoption of surgical simulators by a broad range of specialties. The fact that they have relatively higher capital budgets, already existing training infrastructure, strong incentives to minimize surgical errors, operative time, and complication rates also favors adoption. This trend is still being strengthened by industry developments. In 2025, hospitals around the world started using Surgical Science's RobotiX Express, demonstrated at SRS 2025 in Strasbourg as an affordable, portable, and high-fidelity robot-surgery training platform. This increasing adoption and acceptance by the global surgical community demonstrates the increasing hospital adoption and strong reaffirmation of hospitals as the most significant end users in the surgical simulation market.

North America dominated the global surgical simulation market in 2024.

North America led the global surgical simulation market in 2024 and is expected to maintain leadership during the forecast period because of the advanced health infrastructure, early adoption of simulation-based training, & the strong presence of leading simulation and medtech companies. Intensifying patient safety and quality pressures are key demand drivers, with preventable surgical errors continuing: The Joint Commission reported that wrong-site/wide-patient surgeries and unintended retained foreign objects each accounted for 8% of US sentinel events in 2023, with sharp year-over-year increases. A 2024 BMJ multicenter US study that showed that 38% of surgical patients experienced perioperative adverse events, nearly 60% of which were potentially preventable, further highlights these gaps and highlights the value of simulation in error reduction and competency validation. Almost 98% of the approximately 2.68 million da Vinci procedures performed globally in 2024 were estimated to take place in the US. This is further accelerated by the high volume and complexity of procedures, particularly robotic surgery. North America's market dominance is further reinforced by favorable reimbursement frameworks, the accreditation-driven training mandate, and ongoing investments by academic and teaching.

Key Players

Prominent players in the surgical simulation market include Surgical Science Sweden AB (Sweden), Laerdal Medical (Norway), Elevate Healthcare (US), Intuitive Surgical (US), Mentice AB (Sweden), VirtaMed AG (Switzerland), Gaumard Scientific (US), Simulab Corporation (US), Limbs & Things Ltd. (UK), Medtronic (Ireland), Osso VR (US), 3B Scientific (Germany), SIMULAIDS (US), TruCorp (UK), ImmersiveTouch, Inc. (US), Fundamental XR (UK), Kyoto Kagaku Co., Ltd. (Japan), SimX (Madison Industries) (US), Inovus Limited (UK), and Avkin (US).

Don’t miss out on business opportunities in Surgical Simulation Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/